ALTIS BIOSYSTEMS, INC.

Profile

Company Names

ALTIS BIOSYSTEMS, INC.

Addresses

6 DAVIS DRIVE, SUITE 159, DURHAM, NC 27709

1289 FORDHAM BLVD., SUITE A234, CHAPEL HILL, NC 27514

Phone Numbers

516-255-7290

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$6,593,034.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-03-31 
$2,126,307.00 
$2,250,000.00 
$123,693.00 
Equity 
2
2022-07-20 
$1,363,658.00 
$5,000,000.00 
$3,636,342.00 
Equity 
1
2019-12-30 
$3,103,069.00 
$3,103,069.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
BIRON 
EXECUTIVE OFFICER, DIRECTOR
ALTIS BIOSYSTEMS, INC.
KEVIN 
 
CAUSEY 
DIRECTOR
ALTIS BIOSYSTEMS, INC.
MICHAEL 
 
DIAL 
DIRECTOR
CLINICAL FUTURE, INC.   |  CUROVERSE, INC.   |  KINODYN, INC.   |  RIBOMETRIX, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  ATSENA THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  ALTIS BIOSYSTEMS, INC.   |  HATTERAS CREATE SF SPV, LLC
SAMUEL 
 
FRANKLIN 
DIRECTOR
ALTIS BIOSYSTEMS, INC.
SUSAN 
 
MAHONY 
DIRECTOR
ALTIS BIOSYSTEMS, INC.   |  KOVINA THERAPEUTICS INC.   |  ZYMEWORKS INC.
JOSEPH 
 
MCMAHON 
DIRECTOR
KBI BIOPHARMA INC.   |  ALTIS BIOSYSTEMS, INC.
CHRISTOPHER 
 
PERKINS 
DIRECTOR
ADVANCED MAGLEV SYSTEMS, LLC   |  ALTIS BIOSYSTEMS, INC.   |  CF SERIES DAT A LP   |  QUATREFOIL DATA SERVICES, INC.
BENJAMIN 
 
SCRUGGS 
DIRECTOR, EXECUTIVE OFFICER
IMMVENTION THERAPEUTIX, INC.   |  VERALOX THERAPEUTICS INC.   |  ALTIS BIOSYSTEMS, INC.
CHRISTOPHER 
 
SIMS 
EXECUTIVE OFFICER, DIRECTOR
AFCV HOLDINGS LLC   |  AI SOFTWARE, LLC   |  CELL MICROSYSTEMS, INC.   |  ALTIS BIOSYSTEMS, INC.   |  AI SOFTWARE HOLDINGS, LLC
JIMMY 
 
SMEDLEY 
EXECUTIVE OFFICER
ALTIS BIOSYSTEMS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-04-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-31 
2022-08-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-20 
2020-07-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-30 
2020-01-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#